Bridging the Gap: Conference Workbook [International Conference on AIDS (12th: 1994: Geneva, Switzerland)]

Wednesday, July 1

ORA SESIN 110 -23 13.0-1.3

C33 Recent Diffusion of Drug Injecting:
Identification and response
Chairs: Sujata Rana, Alex Wodak
Venue: Satellite Hall 2000
Time: 11.00-12.30
361 Diffusion of injecting drug use in transitional societies:
Russian Federation and newly independent states
Lev Khodakevich
362 Spread of injecting drug use in South and Southeast Asia developing:
Asian harm reduction network
PalaniNarayan
363 Community-based programmes to prevent the spread of
injecting drug use
Suresh Kumar
364 Potential spread of injecting drug use into high vulnerability
populations in West Africa
MorufAdelekan
365 Rapid assessment methods and intervention development for
injecting and HIV-infection
Gerry Stimson
366 Injecting drug users' viewpoints
Annie Madden
D31 Panel: Approaches to Women-Centered Prevention
Chairs: Suzanne Desbiens, Purnima Mane 0
Venue: Session Hall I
Time: 11.00-12.30
367 Overview: issues and challenges in female-controlled prevention
Maxine Ankrah
368 Empowering women: meeting the challenge in a clinical setting
Erica Gollub
369 Responding to reality: integrating family planning and STD prevention
post-ICPD
Jodi Jacobson
D32 Involving the Community in HIV/AIDS Prevention 0
and Care
Chairs: Mary Crewe, S. Sundararaman
Venue: Session Hall II
Time: 11.00-12.30

A32
Chairs:
Venue:
Time:

Molecular Biology/New Targets
Lutz. G. Gurtler, Ramond F. Schinazi
Session Hall III
13.00-14.30

376 Inhibition of HIV-1 reverse transcription by
actinomycin D (Act D): A potential approach for AIDS therapy
Judith G. Levin* J. Guo; T Wu;J. Bess; L.E. Henderson, USA
377 HIV-1 Vif is an endogenous inhibitor of HIV-1 protease and
peptide derivatives of Vif inhibit Gag-Pol processing and
HIV-1 replication
David Volsky*" P Sova; M. Simm; C. Krachmarov; T Muir;
R.J. Potash, USA
378 Compensatory point mutations in the HIV gag region that are
distal from deletion mutations in the dimerization initiation
site can restore viral replication
Mark A. Wainberg*; Chen Liang; Liwei Rong, Canada
379 The impact of interactions between NC, viral RNA and
protease of HIV-1 on infectious virion assembly
Susan Erickson-Viitanen*; D. Ozturk; H.K. Choi; R. Tritch;
R. Meade; A. Draganescu; P Cawood, USA
380 Quantitative molecular analysis of RNA expression of
HIV-infected T cell using high density oligonucleotide arrays
Jacques Corbeil*; TR. Gingeras; G. Mamtora; D. Huang;
D.D. Richman, USA
381 Molecular mechanisms of HIV-1 nuclear import: MA and
Vpr are the key regulators
Michael Bukrinsky; S. Popov, USA

11124
11130
11126
11131
11139
11144

A33
Chairs:
Venue:
Time:

Viral Reservoirs
Francoise F. Brun-Vezinet, Soleymane Mboup
Session Hall VII
13.00-14.30

382 Lymphocytes and lymph nodes
Ashley Haase
383 Dendritic cells
Melissa Pope
384 HIV and macrophages
Jan Orenstein

370 Introduction
Jeffrey O'Malley
371 Strengthening the community response to the HIV
epidemic in Senegal
Elizabeth Reid*; Moustapha Gueye; B. Goumbala, Senegal
372 Mobilization of communities for social change through risk
behaviour mapping
Hendrikus Schapink*;Jenance Nyomyo, Tanzania
373 Community-based care for people living with HIV/AIDS
Pimjai Intamoon, Thailand
374 Integration of HIV/AIDS prevention and care at a
community level
Ronaldo Mussauer De Lima*; A. VS. Menezes; E. T Santos-Filho;
R.S. Ramos; H.C. Guerreiro, Brazil
375 Discussant
SmarajitJana*;S. Popov, India
Skills Building Workshops 11.00-14.30: see page 131
for details

34120
13408
34140
34109

NOTES

Pathway Symbols: 0 Gender

S Human Rights 0 Policy

CONFERENCE WORKBOOK

125